122 related articles for article (PubMed ID: 24566406)
1. Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Jain TK; Karunanithi S; Sharma P; Vijay MK; Ballal S; Bal C
Clin Nucl Med; 2014 Nov; 39(11):977-9. PubMed ID: 24566406
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Elboga U; Kalender E; Yilmaz M; Celen YZ; Aktolun C
Clin Nucl Med; 2012 Nov; 37(11):1120-2. PubMed ID: 22996245
[TBL] [Abstract][Full Text] [Related]
3. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of SPECT/CT for equivocal findings on (131)I whole-body scan in a patient with differentiated papillary thyroid cancer.
Choi B; Kim DH; Son SH; Zeon S; Ahn BC
Clin Nucl Med; 2014 Feb; 39(2):e160-2. PubMed ID: 23531738
[TBL] [Abstract][Full Text] [Related]
5. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
Wisotzki C; Friese M; Ehresmann J; Derlin T
Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
[TBL] [Abstract][Full Text] [Related]
6. Unexpectedly expected fetal thyroid function on posttreated radioiodine (131I) SPECT/CT of a patient with differentiated thyroid cancer.
Chamroonrat W; Sritara C; Utamakul C; Kositwattanarerk A; Thamnirat K; Anongpornjossakul Y
Clin Nucl Med; 2014 Nov; 39(11):1017-8. PubMed ID: 25036017
[TBL] [Abstract][Full Text] [Related]
7. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of rare choroid plexus metastasis from papillary thyroid carcinoma with multimodality imaging.
Manzil FF; Bender LW; Scott JW
Clin Nucl Med; 2014 Jun; 39(6):551-3. PubMed ID: 23877529
[TBL] [Abstract][Full Text] [Related]
9. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
[TBL] [Abstract][Full Text] [Related]
10. Unusual 131Iodine uptake in a joint demonstrated by SPECT/CT in a patient with differentiated thyroid cancer.
Ciappuccini R; Aide N; Métayer L; Bardet S
Clin Nucl Med; 2015 Apr; 40(4):332-4. PubMed ID: 25674862
[TBL] [Abstract][Full Text] [Related]
11. Unusual Adrenal and Brain Metastases From Follicular Thyroid Carcinoma Revealed by 131I SPECT/CT.
Zhao Z; Shen GH; Liu B; Kuang AR
Clin Nucl Med; 2016 Jan; 41(1):e53-5. PubMed ID: 26018699
[TBL] [Abstract][Full Text] [Related]
12. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
14. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
15. Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Ozkan E; Araz M; Soydal C; Kucuk NO; Ibis E
Clin Nucl Med; 2012 Jun; 37(6):e160-1. PubMed ID: 22614217
[TBL] [Abstract][Full Text] [Related]
16. SPECT/CT and I131 therapy of brain metastases from follicular variant papillary thyroid carcinoma (FVPTC).
Olson AC; Haugen BR; Walter J; Kwak JJ; Bagrosky BM; Koo PJ
J Clin Endocrinol Metab; 2014 Oct; 99(10):3511-2. PubMed ID: 25057877
[No Abstract] [Full Text] [Related]
17. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
[TBL] [Abstract][Full Text] [Related]
18. 131I-SPECT/CT found an ovarian metastasis covered by iliac metastasis on 131I whole-body scan in a patient with papillary thyroid carcinoma.
Xu YH; Huang XM; Song HJ; Qiu ZL; Luo QY
Clin Nucl Med; 2011 May; 36(5):363-4. PubMed ID: 21467854
[No Abstract] [Full Text] [Related]
19. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
20. 123I accumulation in thoracic neoesophagus masking residual papillary thyroid cancer.
Jackson T; Sabbah N; Iagaru A
Clin Nucl Med; 2015 Feb; 40(2):e150-1. PubMed ID: 24999691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
